These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2743552)

  • 21. Prolonged labetalol infusion for management of severe hypertension and tachycardia in a critically ill trauma patient.
    Goldsmith TL; Barker DE; Strodel WE
    DICP; 1990 Mar; 24(3):235-8. PubMed ID: 2316229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous-Infusion Labetalol vs Nicardipine for Hypertension Management in Stroke Patients.
    Hecht JP; Richards PG
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):460-465. PubMed ID: 29092768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral labetalol versus oral clonidine in the emergency treatment of severe hypertension.
    Atkin SH; Jaker MA; Beaty P; Quadrel MA; Cuffie C; Soto-Greene ML
    Am J Med Sci; 1992 Jan; 303(1):9-15. PubMed ID: 1728876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous labetalol for treatment of postoperative hypertension.
    Leslie JB; Kalayjian RW; Sirgo MA; Plachetka JR; Watkins WD
    Anesthesiology; 1987 Sep; 67(3):413-6. PubMed ID: 3631615
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparison of esmolol and labetalol for the treatment of perioperative hypertension in geriatric ambulatory surgical patients.
    Singh PP; Dimich I; Sampson I; Sonnenklar N
    Can J Anaesth; 1992 Jul; 39(6):559-62. PubMed ID: 1353708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A dose-ranging study of labetalol in moderate to moderately severe hypertension.
    Darmansjah I; Setiawati A; Prabowo P; Sukandar E; Parsoedi I; Ardaya ; Bahry B; Jusman J; Anggraeni E
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):226-31. PubMed ID: 7620693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol.
    Harper A; Murnaghan GA
    Br J Obstet Gynaecol; 1991 May; 98(5):453-9. PubMed ID: 2059591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized, double-blind, hemodynamic evaluation of nifedipine and labetalol in preeclamptic hypertensive emergencies.
    Scardo JA; Vermillion ST; Newman RB; Chauhan SP; Hogg BB
    Am J Obstet Gynecol; 1999 Oct; 181(4):862-6. PubMed ID: 10521743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous labetalol in the management of resistant hypertensive emergency.
    Ngole PM
    Drug Intell Clin Pharm; 1987 Jun; 21(6):512-4. PubMed ID: 3608797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Labetalol for the management of hypertensive crises during surgery of cerebral aneurysm; a haemodynamic study (author's transl)].
    Lüben V; Rieder W; Zierski J; Hempelmann G
    Anasth Intensivther Notfallmed; 1981 Aug; 16(4):184-7. PubMed ID: 7294326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of labetalol on hemodynamics and oxygen consumption in patients in the early period of myocardial infarction].
    Gvatua NA; Mironova OV; Sirenko IuN; Tolstopiatov SM
    Kardiologiia; 1990 Apr; 30(4):30-3. PubMed ID: 2203928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Haemodynamic effects of long-term oral labetalol.
    Edwards RC; Raftery EB
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):733-6. PubMed ID: 791328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive management of hypertensive emergencies and urgencies.
    Mansoor GA; Frishman WH
    Heart Dis; 2002; 4(6):358-71. PubMed ID: 12441013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Labetalol in the treatment of essential hypertension: a single-blind dose ranging study.
    Dux S; Grosskopf I; Boner G; Rosenfeld JB
    J Clin Pharmacol; 1986; 26(5):346-50. PubMed ID: 3700690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical evaluation of intravenous labetalol for the treatment of hypertensive urgency.
    Huey J; Thomas JP; Hendricks DR; Wehmeyer AE; Johns LJ; MacCosbe PE
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):284S-289S. PubMed ID: 3415804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic, pulmonary, and coronary hemodynamic effects of labetalol in hypertensive subjects.
    Mehta J; Feldman RL; Marx JD; Kelly GA
    Am J Med; 1983 Oct; 75(4A):32-9. PubMed ID: 6638039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapy of hypertensive crises with a mono-substance with alpha- and beta-blocking properties (labetalol)].
    Holzer H; Pogglitsch H; Katschnig H; Korthals C
    Wien Med Wochenschr Suppl; 1981; 69():10-3. PubMed ID: 6952657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy.
    Vermillion ST; Scardo JA; Newman RB; Chauhan SP
    Am J Obstet Gynecol; 1999 Oct; 181(4):858-61. PubMed ID: 10521742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous labetalol compared with intravenous nicardipine in the management of hypertension in critically ill patients.
    Malesker MA; Hilleman DE
    J Crit Care; 2012 Oct; 27(5):528.e7-14. PubMed ID: 22300487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative prophylactic and therapeutic effects of intravenous labetalol 0.4 mg/kg and nicardipine 20 μg/kg on hypertensive responses to endotracheal intubation in patients undergoing elective surgeries with general anesthesia: a prospective, randomized, double-blind study.
    Ryu JH; Apfel CC; Whelan R; Jeon YT; Hwang JW; Do SH; Ro YJ; Kim CS
    Clin Ther; 2012 Mar; 34(3):593-604. PubMed ID: 22364823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.